is retatrutide more effective than semaglutide vs. Semaglutide: Weight Loss Comparison What Are the Mechanism Differences
Description
Assessment of thyroid carcinogenic risk and safety profile of GLP-1 receptor agonist semaglutide therapy for diabetes mellitus and obesity: a systematic literature review
Tirzepatide is the first and only FDA-approved dual GIP/GLP-1 receptor agonist
Nauck M, Rizzo M, Johnson A, et al
Ozempic is FDA-approved to treat type 2 diabetes, in conjunction with diet and exercise changes
As is often the case, stopping a medication has consequences
In T2D mice, oral administration of Lactobacillus casei increased the abundance of Bacteroidetes, Bifidobacterium , and Lactob acillus, and butyrate production increased, which stimulated GLP-1 secretion (53)
